Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.

Author: BamatMichael K, CartwrightThomas H, El-RayesBassel F, FakihMarwan G, KingThomas R, MaWen Wee, PoseyJames A, SaifMuhammad Wasif, von BorstelReid W

Paper Details 
Original Abstract of the Article :
Increased susceptibility to 5-fluorouracil (5-FU)/capecitabine can lead to rapidly occurring toxicity caused by impaired clearance, dihydropyrimidine dehydrogenase deficiency, and other genetic variations in the enzymes that metabolize 5-FU. Life-threatening 5-FU overdoses occur because of infusion ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248610/

データ提供:米国国立医学図書館(NLM)

Uridine Triacetate: A Lifeline for 5-Fluorouracil Toxicity

5-Fluorouracil (5-FU) and capecitabine are widely used chemotherapy drugs, but they can cause severe and even life-threatening toxicities. This article describes the use of uridine triacetate (Vistogard), a medication approved for the prevention and treatment of life-threatening 5-FU/capecitabine toxicity. It explains the mechanism of action of uridine triacetate and its role in managing 5-FU/capecitabine overdoses.

A Novel Approach to Chemotherapy Toxicity

Uridine triacetate delivers high concentrations of uridine, which competes with toxic 5-FU metabolites, effectively reducing their harmful effects. This targeted approach can be crucial for managing life-threatening toxicities caused by 5-FU or capecitabine, particularly in cases of accidental overdose or impaired drug clearance. The approval of uridine triacetate represents a significant advancement in the management of chemotherapy toxicity, offering a potentially life-saving intervention.

Navigating the Challenges of Cancer Treatment

As an oncologist, I'm always seeking ways to improve the safety and efficacy of cancer treatments. This article provides valuable information about uridine triacetate, a new tool for managing 5-FU/capecitabine toxicity. It's a reminder that even in the midst of the challenges of cancer treatment, there are ongoing advancements in supportive care, offering hope for patients facing the potential side effects of chemotherapy. This research is like an oasis in the desert of cancer treatment, providing us with new strategies for managing potentially life-threatening toxicities.

Dr.Camel's Conclusion

Uridine triacetate represents a promising new approach to managing 5-FU/capecitabine toxicity, offering a potentially life-saving intervention for patients experiencing severe or life-threatening adverse effects of these chemotherapy drugs. This research is a reminder of the continuous efforts to improve the safety and efficacy of cancer treatments, bringing us closer to a world where cancer patients can receive effective treatment with minimal side effects.

Date :
  1. Date Completed 2017-06-08
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

27622829

DOI: Digital Object Identifier

PMC5248610

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.